From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Pharma manufacturers increasingly find their commercialization strategies are being constrained by their legacy revenue management systems. As a result, many have turned to ICyte, IntegriChain’s purpose-built platform for drug commercialization.
IntegriChain has experts in-house with years of hands-on experience in a broad range of revenue management, contracting, and channel management systems. We have developed a proven, documented process for ensuring a low-risk and validated migration to the ICyte Platform.
Case Study: Big Pharma Conversion of Legacy System
IntegriChain knows that the easiest way to move to and adopt a new operating platform is when it contains your operational and even historical data. To enable you to hit the ground running, our Solutions Delivery team have developed a migration approach that focuses on several key disciplines:
In addition to our market-tested migration methodology, IntegriChain delivers a unique combination of people, process, and technology to ensure zero downtime and migration of key operational and historical data.
Proven Migration TeamDedicated team versed in all aspects of the process reduces risk and ensures a successful outcome. IntegriChain’s BPaaS teams are also involved in project activities to verify customer requirements.
Project AcceleratorsWith decades of experience, IntegriChain has developed automated processes to migrate and validate historical data that speed time-to-value while also reducing the impact of poor-quality data.
Proven Project MethodologiesOur services team has libraries of proven migration methodologies that provide repeatable, predictable results and successful delivery. We also offer our gated system validation approach to ensure accurate results along the migration journey.
Project Management ExpertsOur team of project managers provide accurate, transparent oversight across all facets of the project. With support from product management and other subject matter experts, our project managers ensure clear roles, responsibilities, accountability, and on-time, on-budget delivery.
Talk to Our Migration Team
This case study highlights how IntegriChain delivered their innovative ICyte Saas Platform to help the manufacturer identify and resolve obstacles.
Read the Case Study
Co-Founder and Chief Executive Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization.
Read the Blog
